Edwards Lifesciences Corporation Common Stock vs Schwab US Large Cap Growth ETF — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while Schwab US Large Cap Growth ETF trades at $36.59 (market cap $65.76B). The key difference: Schwab US Large Cap Growth ETF is the larger of the two by market cap, and Schwab US Large Cap Growth ETF is trading nearer its 52-week high, Edwards Lifesciences Corporation Common Stock nearer its low. Which is the better fit depends on your goals.
| EW | SCHG | |
|---|---|---|
Market Cap | $49.44B | $65.76B |
Volume | 3,508,027 | 8,114,853 |
Sector | Health | Sector/Thematic |
52-Week High | $95.18 | $36.93 |
52-Week Low | $72.65 | $28.10 |
Enterprise Value | $45.90B | — |
Typical Hold Time | — | 50 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SCHG trades at $36.87, down slightly by 0.16% today, with technical indicators showing a bullish moving average trend but overbought RSI signals. The ETF maintains strong institutional interest despite recent position adjustments by some wealth managers. Recent media coverage highlights SCHG's low-cost growth exposure and historical performance advantages over broader market indices.
The outlook remains positive given SCHG's focus on large-cap growth stocks and competitive expense ratio, though concentration risk in top holdings and potential market volatility present challenges. Long-term growth prospects appear favorable based on historical returns and continued investor appetite for growth-oriented strategies.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →SCHG is an ETF that seeks to track the total return of the Dow Jones U.S. Large-Cap Growth Total Stock Market Index. The fund provides low-cost exposure to a diversified portfolio of large-capitalization U.S. companies that are classified as growth stocks based on factors such as sales, earnings, and book value growth rates. SCHG is often used by investors seeking long-term capital appreciation from market-leading companies with above-average growth potential.
Read more on SCHG →